The role of DNA repair in nitrogen mustard drug resistance

Anti-Cancer Drugs

Volumn 13, Issue 3, 2002, Pages 211-220

  Panasci, Lawrence ^a,b   Xu, Zhi Yuan ^a   Bello, Vanessa ^a   Aloyz, Raquel ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

DNA repair; Drug resistance; Nitrogen mustards

Indexed keywords

CHLORAMBUCIL; CHLORMETHINE; CROSS LINKING REAGENT; RAD51 PROTEIN;

ANIMAL CELL; APOPTOSIS; CANCER RESISTANCE; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CROSS LINKING; DNA REPAIR; DRUG RESISTANCE; EPITHELIUM TUMOR; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; HYPERSENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; FORECASTING; HUMANS; NEOPLASM PROTEINS; NITROGEN MUSTARD COMPOUNDS; RECOMBINATION, GENETIC;

EID: 0036255553     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200203000-00002     Document Type: Review

References (86)

1. Alkylating agents in clinical chemotherapy
2. The treatment of plasma cell myeloma
3. L-phenylalanine mustard (L-Pam) in the management of primary breast cancer
4. Advanced ovarian adenocarcinoma
5. Mechanism of cyclophosphamide transport by L5178Y lymphoblasts in vitro
6. Studies with cyclophosphamide labelled with phosphorus-32: Nucleic acid alkylation and its effect on DNA synthesis in rat tumor and normal tissues
7. Analysis of melphalan adducts of 2′-deoxynucleotides in calf thymus DNA hydrolysates by capillary high-pressure liquid chromatography-electrospray tandem mass spectroscopy
8. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links
9. DNA crosslinking as an indicator of sensitivity and resistance of L1210 leukemia cells to cis-diaminedichloroplatinum (II) and L-phenylalanine mustard
10. Mechanism of melphalan resistance developed in vitro in human melanoma cells
11. Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan
12. Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines
13. Dechlorination of L-phenylalanine mustard by sensitive and resistance tumor cells and its relationship to intracellular glutathione content
14. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion
15. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine
16. Isozyme specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines
17. Overexpression of metallothionein confers resistance to anticancer drugs
18. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
19. Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells
20. A comparative analysis of drug-induced DNA effects in a nitrogen mustard resistant cell line expressing sensitivity in nitrosoureas
21. Reduced levels of drug-induced DNA crosslinking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione-S-transferase activity
22. Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes
23. Interstrand cross-linking of DNA by difunctional alkylating agents
24. Synthesis of a duplex oligonucleotide containing a nitrogen mustard interstrand DNA-DNA cross-link
25. Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay
26. DNA filter elution: A window on DNA damage in mammalian cells
27. Principles and practice of DNA filter elution
28. Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards
29. Detection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity
30. Analysis of chromate-induced DNA-protein crosslinks with the comet assay
31. Chronic lymphocytic leukemia: New insights into biology and therapy
32. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance
33. In vitro chemosensitivity testing in chronic lymphocytic leukaemia patients
34. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs
35. Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia
36. Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links
37. In vivo DNA cross-linking by cyclophosphamide: Comparison of human lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells
38. Glutathione S-transferase activity, sulfhydryl group and glutathione levels and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia
39. Enhanced DNA cross-link removal: The apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line
40. Repair of DNA interstrand crosslinks after busulphan. A possible mode of resistance
41. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation
42. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells
43. Formation and repair of 1,3-bis-(2-chloroethyl)-1-nitrosourea and cisplatin induced total genomic DNA interstrand crosslinks in human glioma cells
44. Repair analysis of 4-hydro-peroxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydro-peroxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines
45. Walker rat carcinoma cells are exceptionally sensitive to cis-diamminedi-chloroplatinum(II) (cisplatin) and other difunctional agents but not defective in the removal of platinum-DNA adducts
46. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity
47. Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins
48. Excision of DNA adducts of nitrogen mustards by bacterial and mammalian 3-methyladenine-DNA glycosylases
49. Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukaemia resistant to nitrogen mustards
50. Effect of alkyl-N-purine DNA glycosylase overexpression on cellular resistance to bifunctional alkylating agents
51. Mammalian 3-methyl-adenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents
52. Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents
53. Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents
54. The scid mutation in mice causes defects in the repair system for both double strand DNA breaks and DNA cross-links
55. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination
56. XRCC2 and XRCC3, new human Rad51 family members, promote chromosome stability and protect against DNA crosslinks and other damages
57. Evidence that mammalian cells possess homologous recombinational repair pathways
58. Homologous recombinational repair of DNA ensures mammalian chromosome stability
59. The nuclear serine/threonine protein kinase DNA-PK
60. DNA-PK at the cross-roads of biochemistry and genetics
61. Rad51/RecA protein families and the associated proteins in eukaryotes
62. DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance
63. DNA repair activity in protein extracts of fresh human malignant lymphoid cells
64. The sensitivity of chronic lymphocytic leukaemia lymphocytes to irradiation in vitro
65. Human cells contain a DNA-activated protein-kinase that phosphorylates simian virus 40T antigen, mouse p53 and the human Ku autoantigen
66. Regulation of DNA dependent protein kinase activity in leukemic cells
67. DNA-dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards
68. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin
69. Xrcc3 protein expression and induction of Rad51 foci correlate with melphalan resistance in human tumor cell lines
70. DNA-dependent protein kinase, the DNA-activated protein kinase is differentially expressed in normal and malignant human tissues
71. DNA-dependent protein kinase
72. DNA-dependent protein kinase catalytic subunit: A target for an ICE-like protease in apoptosis
73. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
74. ATM mutations in B-cell chronic lymphocytic leukemia
75. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
76. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
77. Initiation of DNA interstrand crosslink repair in humans: The nucleotide excision repair system makes dual incisions 5′ to the cross-linked base and removes a 22 to 28-nucleotide-long damage-free strand
78. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand crosslinks in mammalian cells
79. Studies of the interaction between Rad52 protein and the yeast single-stranded DNA binding protein RPA
80. Xrcc3 is required for assembly of Rad51 complexes in vivo
81. Mouse Rad54 affects DNA conformation and DNA-damaged induced Rad51 foci formation
82. Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes
83. Chlormabucil induction of HsRad51 in B-cell chronic lymphocytic leukemia
84. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance
85. Binding of double-strand breaks in DNA by human Rad52 protein
86. XPD might play an important role in DNA repair